121 related articles for article (PubMed ID: 10187349)
1. Miracle vaccines. Advances in genetic engineering are spawning a new generation of powerful disease fighters.
Schrof JM
US News World Rep; 1998 Nov; 125(20):56-9, 62-7. PubMed ID: 10187349
[No Abstract] [Full Text] [Related]
2. [Trends in the studies of the preparations of active and passive immunization. Bacterial vaccines].
Gałazka A
Przegl Epidemiol; 1988; 42(4):317-31. PubMed ID: 3247475
[No Abstract] [Full Text] [Related]
3. Cytokine gene-engineered vaccines.
Forni G; Boggio K
Curr Opin Mol Ther; 1999 Feb; 1(1):34-8. PubMed ID: 11249681
[TBL] [Abstract][Full Text] [Related]
4. The impact of new technologies on vaccines.
Talwar GP; Diwan M; Razvi F; Malhotra R
Natl Med J India; 1999; 12(6):274-80. PubMed ID: 10732430
[TBL] [Abstract][Full Text] [Related]
5. [New advances in clinical trials of cancer vaccines].
Peng F; Wei YQ
Ai Zheng; 2006 Aug; 25(8):1059-62. PubMed ID: 16965694
[TBL] [Abstract][Full Text] [Related]
6. Vaccines: more reasons to immunize.
Consum Rep; 2006 Oct; 71(10):62. PubMed ID: 16981311
[No Abstract] [Full Text] [Related]
7. [Use of genetic engineering methods to create viral vaccines].
Tatarov G
Vet Med Nauki; 1987; 24(1):88-92. PubMed ID: 3303657
[No Abstract] [Full Text] [Related]
8. The use of picornaviruses as vectors for the engineering of live recombinant vaccines.
Girard M; Altmeyer R; van der Werf S; Wychowski C; Martin A
Biologicals; 1995 Jun; 23(2):165-9. PubMed ID: 7546659
[No Abstract] [Full Text] [Related]
9. The development of antimicrobials and vaccines against bacterial bioterrorism agents--where are we?
Gilligan PH
Drug Discov Today; 2004 Mar; 9(5):205-6. PubMed ID: 14980537
[No Abstract] [Full Text] [Related]
10. Childhood vaccine finance and safety issues.
Giffin R; Stratton K; Chalk R
Health Aff (Millwood); 2004; 23(5):98-111. PubMed ID: 15371374
[TBL] [Abstract][Full Text] [Related]
11. Recombinant cancer vaccines based on viral vectors.
Moingeon P
Dev Biol (Basel); 2004; 116():117-22; discussion 133-43. PubMed ID: 15603188
[TBL] [Abstract][Full Text] [Related]
12. A critique of criteria for evaluating vaccines for inclusion in mandatory school immunization programs.
Opel DJ; Diekema DS; Marcuse EK
Pediatrics; 2008 Aug; 122(2):e504-10. PubMed ID: 18676536
[TBL] [Abstract][Full Text] [Related]
13. [Children immunization in France: an update].
Garnier JM; Retornaz K; Noël G; Minodier P
Rev Prat; 2004 Mar; 54(5):489, 491-8. PubMed ID: 15176505
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in biomolecular engineering.
Ryu DD; Nam DH
Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
[TBL] [Abstract][Full Text] [Related]
15. First World Diabetes Day calls for global action on disease.
Yan L; Galvan A
Nephrol News Issues; 2008 Jan; 22(1):23-4. PubMed ID: 18271433
[No Abstract] [Full Text] [Related]
16. Tobacco pharming. A quest to turn the killer crop into a treatment for cancer.
Powledge TM
Sci Am; 2001 Oct; 285(4):25-6. PubMed ID: 11570039
[No Abstract] [Full Text] [Related]
17. Gas vaccine. Bioengineered immunization could shield against nerve gas.
Fischetti M
Sci Am; 1991 Apr; 264(4):153-4. PubMed ID: 1876820
[No Abstract] [Full Text] [Related]
18. [Synthetic gene technology for new vaccines].
Mäkelä PH
Duodecim; 1988; 104(22):1874-80. PubMed ID: 3065068
[No Abstract] [Full Text] [Related]
19. Alphavirus-based vaccines.
Lundstrom K
Curr Opin Mol Ther; 2002 Feb; 4(1):28-34. PubMed ID: 11883692
[TBL] [Abstract][Full Text] [Related]
20. GM cows face slaughter in multiple sclerosis experiment.
Brockie B
Nature; 2001 May; 411(6836):402. PubMed ID: 11373631
[No Abstract] [Full Text] [Related]
[Next] [New Search]
